Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
İbrahim Halil Şahin, Mehmet Akce, Olatunji B. Alese, et al.
British Journal of Cancer (2019) Vol. 121, Iss. 10, pp. 809-818
Open Access | Times Cited: 312

Showing 1-25 of 312 citing articles:

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Dongrui Wang, Xianlin Wu, Yingli Sun
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 290
Targeting the DNA damage response in immuno-oncology: developments and opportunities
Roman M. Chabanon, Mathieu Rouanne, Christopher J. Lord, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 11, pp. 701-717
Closed Access | Times Cited: 214
Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
Eric Koncina, Serge Haan, Stefan Rauh, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 319-319
Open Access | Times Cited: 201
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
Xinyang Zhong, Xuefeng He, Yaxian Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 154
Mechanisms driving the immunoregulatory function of cancer cells
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 145
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Sreyashi Das, Mohan Kumar Dey, Ram V. Devireddy, et al.
Sensors (2023) Vol. 24, Iss. 1, pp. 37-37
Open Access | Times Cited: 105
Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
Winnie Fong, Qing Li, Fenfen Ji, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2272-2285
Open Access | Times Cited: 94
Predictive biomarkers of colon cancer immunotherapy: Present and future
Wanting Hou, Yi Cheng, Hong Zhu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 90
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 62
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
Andrea Nicolini, Paola Ferrari
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Decoding the functional impact of the cancer genome through protein–protein interactions
Haian Fu, Xiulei Mo, Andrei A. Ivanov
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study
Xiaolei Wang, Yuxia Huang, Zhen Yang, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Current advancements and future perspectives of immunotherapy in colorectal cancer research
Chandra Kishore, Priyanka Bhadra
European Journal of Pharmacology (2020) Vol. 893, pp. 173819-173819
Closed Access | Times Cited: 116
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
Gabriele Picco, Chiara M. Cattaneo, Esmée J. van Vliet, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 1923-1937
Open Access | Times Cited: 73
Lynch Syndrome and MSI-H Cancers: From Mechanisms to “Off-The-Shelf” Cancer Vaccines
Vladimir Roudko, Cansu Cimen Bozkus, Benjamin Greenbaum, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 67
High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors
Lauren Stopfer, Cameron T. Flower, Aaron S. Gajadhar, et al.
Cancer Research (2021) Vol. 81, Iss. 9, pp. 2495-2509
Open Access | Times Cited: 64
New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer
Lu Lu, Jiahuan Dong, Yujing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 63
Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
Jinhui Liu, Rui Geng, Senmiao Ni, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 27, pp. 1036-1055
Open Access | Times Cited: 58
Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
Andrea Aran, Laia Garrigós, Giuseppe Curigliano, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1771-1771
Open Access | Times Cited: 41
Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues
İbrahim Halil Şahin, Kristen K. Ciombor, Luis A. Díaz, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 242-253
Open Access | Times Cited: 41
Microbial metabolites in colorectal tumorigenesis and cancer therapy
Yali Liu, Harry Cheuk-Hay Lau, Jun Yu
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 34
A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance
Ginette S. Santiago-Sánchez, Kellsye P. Fabian, James W. Hodge
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 15
Next-generation therapies for pancreatic cancer
Conor Buckley, Eileen M. O’Reilly
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 1-3, pp. 55-72
Open Access | Times Cited: 15
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Advancements in Colorectal Cancer Treatment: The Role of Metal-Based and Inorganic Nanoparticles in Modern Therapeutic Approaches
Maryam Azarian, Marzieh Ramezani Farani, William C. Cho, et al.
Pathology - Research and Practice (2024) Vol. 264, pp. 155706-155706
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top